Literature DB >> 23701935

Prognostic value of cardiovascular magnetic resonance in patients with suspected arrhythmogenic right ventricular cardiomyopathy.

Monica Deac1, Francisco Alpendurada, Fariba Fanaie, Raj Vimal, John-Paul Carpenter, Adelle Dawson, Chris Miller, Isabelle Roussin, Elisa di Pietro, Tevfik F Ismail, Michael Roughton, Joyce Wong, Dana Dawson, Janice A Till, Mary N Sheppard, Raad H Mohiaddin, Philip J Kilner, Dudley J Pennell, Sanjay K Prasad.   

Abstract

BACKGROUND: Early recognition and accurate risk stratification are important in the management of arrhythmogenic right ventricular cardiomyopathy (ARVC). Identification of predictors of outcome by cardiovascular magnetic resonance (CMR) in patients undergoing evaluation for ARVC is limited. We investigated the predictive value of morphological abnormalities detected by CMR for major clinical events in patients with suspected ARVC.
METHODS: We performed a longitudinal study on 369 consecutive patients with at least one criterion for ARVC. Abnormal CMR was defined by the presence of one of the following: increased right ventricular (RV) volumes, reduced RV ejection fraction, RV regional wall motion abnormalities, myocardial fatty infiltration, and myocardial fibrosis. The end-point was a composite of cardiac death, sustained ventricular tachycardia, ventricular fibrillation, and appropriate ICD discharge.
RESULTS: Twenty patients met the composite end-point over a mean follow-up of 4.3±1.5 years. An abnormal CMR was an independent predictor of outcomes (p<0.001). The presence of multiple abnormalities heralded a particular high risk of events (HR 23.0, 95% CI 5.7-93.2, p<0.001 for 2 abnormalities; HR 35.8, 95% CI 9.7-132.6, p<0.001 for 3 or more abnormalities). The positive predictive value of an abnormal CMR study was 21.0% for an adverse event, whilst the negative predictive value of a normal CMR study was 98.8% over the follow-up period.
CONCLUSIONS: CMR provides important prognostic information in patients under evaluation for ARVC. A normal study portends a good prognosis. Conversely, the presence of multiple abnormalities identifies a high risk group of patients who may benefit from ICD implantation.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Arrhythmogenic right ventricular cardiomyopathy; Cardiovascular magnetic resonance; Prognosis

Mesh:

Year:  2013        PMID: 23701935     DOI: 10.1016/j.ijcard.2013.04.208

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  15 in total

1.  [Cardiological diseases].

Authors:  L Gross; S Massberg; D Sibbing
Journal:  Internist (Berl)       Date:  2013-10       Impact factor: 0.743

Review 2.  Noninvasive Multimodality Imaging in ARVD/C.

Authors:  Anneline S J M Te Riele; Harikrishna Tandri; Danita M Sanborn; David A Bluemke
Journal:  JACC Cardiovasc Imaging       Date:  2015-05

3.  Epicardial Conduction Speed, Electrogram Abnormality, and Computed Tomography Attenuation Associations in Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  Tuna Ustunkaya; Benoit Desjardins; Riley Wedan; C Anwar A Chahal; Stefan L Zimmerman; Nissi Saju; Sohail Zahid; Apurva Sharma; Yuchi Han; Natalia Trayanova; Francis E Marchlinski; Hugh Calkins; Harikrishna Tandri; Saman Nazarian
Journal:  JACC Clin Electrophysiol       Date:  2019-08-28

Review 4.  Impact of cardiac magnetic resonance imaging in non-ischemic cardiomyopathies.

Authors:  Kevin Kalisz; Prabhakar Rajiah
Journal:  World J Cardiol       Date:  2016-02-26

5.  Association of regional epicardial right ventricular electrogram voltage amplitude and late gadolinium enhancement distribution on cardiac magnetic resonance in patients with arrhythmogenic right ventricular cardiomyopathy: Implications for ventricular tachycardia ablation.

Authors:  Shuanglun Xie; Benoit Desjardins; Maciej Kubala; Jackson Liang; Jiandu Yang; Rob J van der Geest; Robert Schaller; Michael Riley; David Callans; Erica Zado; Francis Marchlinski; Saman Nazarian
Journal:  Heart Rhythm       Date:  2018-03-02       Impact factor: 6.343

Review 6.  Arrhythmogenic right ventricular cardiomyopathy: From genetics to diagnostic and therapeutic challenges.

Authors:  Bruno Pinamonti; Francesca Brun; Luisa Mestroni; Gianfranco Sinagra
Journal:  World J Cardiol       Date:  2014-12-26

7.  Arrhythmogenic Cardiomyopathy - New Insights into Disease Mechanisms and Drug Discovery.

Authors:  Angeliki Asimaki; André G Kléber; Calum A MacRae; Jeffrey E Saffitz
Journal:  Prog Pediatr Cardiol       Date:  2014-12-01

8.  Response to Letter Regarding Article, "Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement".

Authors:  Domenico Corrado; Thomas Wichter; Mark S Link; Richard Hauer; Frank Marchlinski; Aris Anastasakis; Barbara Bauce; Cristina Basso; Corinna Brunckhorst; Adalena Tsatsopoulou; Harikrishna Tandri; Matthias Paul; Christian Schmied; Antonio Pelliccia; Firat Duru; N A Mark Estes; William J McKenna; Gaetano Thiene; Frank I Marcus; Hugh Calkins
Journal:  Circulation       Date:  2016-03-15       Impact factor: 29.690

Review 9.  Multimodality imaging predictors of sudden cardiac death.

Authors:  Fancesco Bandera; Lilit Baghdasaryan; Giulia Elena Mandoli; Matteo Cameli
Journal:  Heart Fail Rev       Date:  2020-05       Impact factor: 4.214

10.  European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population.

Authors:  Jens Cosedis Nielsen; Yenn-Jiang Lin; Marcio Jansen de Oliveira Figueiredo; Alireza Sepehri Shamloo; Alberto Alfie; Serge Boveda; Nikolaos Dagres; Dario Di Toro; Lee L Eckhardt; Kenneth Ellenbogen; Carina Hardy; Takanori Ikeda; Aparna Jaswal; Elizabeth Kaufman; Andrew Krahn; Kengo Kusano; Valentina Kutyifa; Han S Lim; Gregory Y H Lip; Santiago Nava-Townsend; Hui-Nam Pak; Gerardo Rodríguez Diez; William Sauer; Anil Saxena; Jesper Hastrup Svendsen; Diego Vanegas; Marmar Vaseghi; Arthur Wilde; T Jared Bunch; Alfred E Buxton; Gonzalo Calvimontes; Tze-Fan Chao; Lars Eckardt; Heidi Estner; Anne M Gillis; Rodrigo Isa; Josef Kautzner; Philippe Maury; Joshua D Moss; Gi-Byung Nam; Brian Olshansky; Luis Fernando Pava Molano; Mauricio Pimentel; Mukund Prabhu; Wendy S Tzou; Philipp Sommer; Janice Swampillai; Alejandro Vidal; Thomas Deneke; Gerhard Hindricks; Christophe Leclercq
Journal:  Europace       Date:  2020-08-01       Impact factor: 5.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.